Camena Bioscience
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Saffron Walden, Cambridge, Cambridgeshir...Website
www.camenabio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Camena Bioscience
Camena Bioscience specializes in advanced DNA synthesis technology through its gSynth platform, which enables high-throughput production of synthetic genes of any sequence, length, and complexity. Their innovative approach accelerates discovery pipelines in biotechnology, particularly for applications in personalized mRNA vaccines, cell and gene therapies, and CRISPR screening. Committed to sustainability, Camena's technology reduces waste in the healthcare sector while ensuring the security of proprietary DNA sequences. Their solutions address the rising demand for unique DNA templates, facilitating the development of life-saving therapeutics.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Camena Bioscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Camena Bioscience
Click to see if Camena Bioscience had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Camena Bioscience is spiking on competitors!
Funding: Get notified immidiatlly once Camena Bioscience has new funding data
Product Launch: Get notified when Camena Bioscience launches new products
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Camena Bioscience recently announced quarterly report
Camena Bioscience, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Camena Bioscience has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Camena Bioscience
Find 2 more new buyers
Compare Similar Companies to Camena Bioscience
Compare insights from companies similar to Camena Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Camena Bioscience
<$5M
11-50
Private
$10M
2016
N/A
Company Profile Activity
Activity Insights
Camena Bioscience is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Camena Bioscience is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Camena Bioscience.
Camena Bioscience financials insights
Gather financial insights about Camena Bioscience, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$10M
Camena Bioscience Tech Stack
A closer look at the technologies used by Camena Bioscience
See more technologies
Most Recent Scoops
Person-Based
Person-Based
Executive Move
Board of Directors
Funding
Camena Bioscience News & Media
Camena Bioscience Eyes DNA Synthesis Market With 'TdT-Free' Enzymatic Technology
The synbio firm said its new enzymatic technology improves the quality and speed of DNA synthesis but has not revealed much of its manufacturing process.Camena Bioscience Closes $10m Series A Financing as Demand for DNA Synthesis Technology Increases
CAMBRIDGE, England--(BUSINESS WIRE)--Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, today announced it has closed a $10m Series A financing round, led by Mercia. The new funding will be used to scale operations and continue development of its pioneering DNA synthesis platform, gSynth™. Camena is the first company to offer this unique and highly accurate enzyme-based DNA synthesis technology. It has already signed commercial agr
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Camena Bioscience
Sign Up For FreeTo access detailed company insights
Camena Bioscience specializes in advanced DNA synthesis technology through its gSynth platform, which enables high-throughput production of synthetic genes of any sequence, length, and complexity. Their innovative approach accelerates discovery pipelines in biotechnology, particularly for applications in personalized mRNA vaccines, cell and gene th... Read More
